ภาควิชากุมารเวชศาสตร์ | คณะแพทยศาสตร์ศิริราชพยาบาล มหาวิทยาลัยมหิดล

1.

Mehra S.; Kludkleeb S.; Chaimayo C.; Leaungwutiwong P.; Lawpoolsri S.; Pan-ngum W.; Chokephaibulkit K.; Ngamprasertchai T.

Unveiling immunity gaps and determining a suitable age for a third dose of the measles-containing vaccine: a strategic approach to accelerating measles elimination
The Lancet Regional Health - Southeast Asia. 2025. 32

2.

Puthanakit T.; Chokephaibulkit K.; Anugulruengkitt S.; Chaithongwongwatthana S.; Phongsamart W.; Wittawatmongkol O.; Rungmaitree S.; Tang Y.; Kerdsomboon C.; Yuwaree V.; Fortuna L.; Mansouri S.; Pham H.T.; Bhat N.; Innis B.L.

Infant Responses to Primary Immunization Following Vaccination in Pregnancy With Varying Doses of Recombinant Acellular Pertussis Vaccine Alone or Combined With Tetanus-Diphtheria
Pediatric Infectious Disease Journal. 2025. 44 (2): S56-S60.

3.

Wang S, Thitilertdecha P, Khowawisetsut L, Maneesawat T, Chuansumrit A, Chokephaibulkit K, Pattanapanyasat K, Onlamoon N.

Dengue Viral Infection Induces Alteration of CD95 Expression in B Cell Subsets with Potential Involvement of Dengue Viral Non-Structural Protein 1
Viruses. 2025. 17 (4):

4.

Phatharodom P, Maleesatharn A, Sudjaritruk T, Khusuwan S, Petoumenos K, Aurpibul L, Chaiwarith R, Giles ML, Quy DT, Nimkar S, Widhani A, Tanuma J, Law M, Sohn AH, Chokephaibulkit K; IeDEA Asia‐Pacific.

Differences in clinical characteristics between adolescents and young adults with perinatally and sexually acquired HIV in the Asia-Pacific region
Journal of the International AIDS Society. 2025. 28 (4):

5.

Piyaphanee N, Charuvanij S, Thepveera S, Toh ZQ, Licciardi PV, Pattaragarn A, Wongprompitak P, Boonnak K, Pheerapanyawaranun C, Chokephaibulkit K.

Immunogenicity and safety of BNT162b2 vaccination in adolescents with systemic lupus erythematosus
Lupus. 2024. 33 (5): 450-461.

6.

Assantachai P.; Niyomnaitham S.; Toh Z.Q.; Thammasalee M.; Pengsorn N.; Monklang W.; Licciardi P.V.; Chokephaibulkit K.

Immunogenicity and reactogenicity of repeated intradermal mRNA COVID-19 vaccines administered as a second booster dose in a Thai geriatric population
Frontiers in Immunology. 2024. 14

7.

Chiaprasert P.; Lolekha R.; Rungmaitree S.; Maleesatharn A.; Sethaputra C.; Durier Y.; Srisoonthonthai P.; Pumpradit W.; Northbrook S.C.; Weerarak P.; Chokephaibulkit K.

Outreach strategies to promote HIV testing and linkage-to-care focusing on a young sexual and gender-diverse population in Bangkok, Thailand
PLoS ONE. 2024. 19 (1):

8.

Rungmaitree S, Werarak P, Pumpradit W, Phongsamart W, Lapphra K, Wittawatmongkol O, Durier Y, Maleesatharn A, Kuttiparambil B, Cressey TR, Hoffman RM, Chokephaibulkit K.

A pilot program of HIV pre-exposure prophylaxis in Thai youth
PLoS One. 2024. 19 (2):

9.

Piyaphanee N.; Charuvanij S.; Thepveera S.; Toh Z.Q.; Licciardi P.V.; Pattaragarn A.; Wongprompitak P.; Boonnak K.; Pheerapanyawaranun C.; Chokephaibulkit K.

Immunogenicity and safety of BNT162b2 vaccination in adolescents with systemic lupus erythematosus
Lupus. 2024.

10.

Ounchanum P.; Achalapong J.; Teeraananchai S.; Gatechompol S.; Phongsamart W.; Chokephaibulkit K.; Tran D.N.H.; Dang H.L.D.; Teeratakulpisarn N.; Chalermchockcharoenkit A.; Singtoroj T.; Sohn A.H.; Phanuphak N.

The effects of bivalent human papillomavirus (HPV) vaccination on high-risk anogenital HPV infection among sexually active female adolescents with and without perinatally acquired HIV
Sexual health. 2024. 21 (1):

ผลงานที่ได้รับการตีพิมพ์